Cargando…
Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial
BACKGROUND: Pain due to oral mucositis (OM) is a major problem during concurrent chemoradiotherapy (CCRT) in nasopharyngeal carcinoma (NPC) patients. METHODS: We enrolled 56 NPC patients receiving CCRT and allocated them into two groups: moderate pain group (n = 27) and a severe pain group (n = 29)...
Autores principales: | Hua, Xin, Chen, Lin-Min, Zhu, Qian, Hu, Wen, Lin, Chao, Long, Zhi-Qing, Wen, Wen, Sun, Xiao-Qing, Lu, Zi-Jian, Chen, Qiu-Yan, Luo, Dong-Hua, Sun, Rui, Mo, Hao-Yuan, Tang, Lin-Quan, Zhang, Wen-Wen, He, Zhen-Yu, Mai, Hai-Qiang, Lin, Huan-Xin, Guo, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726700/ https://www.ncbi.nlm.nih.gov/pubmed/30712098 http://dx.doi.org/10.1007/s00520-019-4643-5 |
Ejemplares similares
-
Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy
por: Hua, Xin, et al.
Publicado: (2021) -
Low Skeletal Muscle Mass Impairs Quality of Life in Nasopharyngeal Carcinoma Patients Treated With Concurrent Chemoradiotherapy
por: Hua, Xin, et al.
Publicado: (2020) -
A Model Combining Skeletal Muscle Mass and a Hematological Biomarker to Predict Survival in Patients With Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy
por: Huang, Han-Ying, et al.
Publicado: (2021) -
Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis
por: Li, Yang, et al.
Publicado: (2018) -
Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma
por: Liu, Li-Ting, et al.
Publicado: (2020)